RAD52 inhibitors (Temple University)

N/A

Report date: 2025/03/19 20:00:56

NME

Base Information

Drug NameRAD52 inhibitors (Temple University)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA repair protein RAD52 homolog inhibitors

TargetsDNA repair protein RAD52 homolog

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTemple University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTemple University

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A